BioCeuticals Clinical AnxioCalm 50t

Description

AnxioCalm is a unique blend of herbs to support symptomatic relief of mild anxiety, tension and stress, formulated to calm and support the nervous system and to minimise the systemic effects of stress. AnxioCalm is standardized to kavalactones 60mg. 

 

• May help relieve nervous tension, stress, mild anxiety and sleeplessness.
• Traditionally used in herbal medicine as a nervine, calmative and mild sedative to help relieve nervousness, restlessness and mild symptoms of mental stress.
• May help to temporarily promote relaxation.
• May assist in the management of anxiety.
• Contains a combination of premium botanicals, including Piper methysticum standardised to contain 10% kavalactones.

No added dairy, gluten, shellfish, soy protein, yeast

Vegan & vegetarian friendly.

• Not for prolonged use.
• If symptoms persist seek advice from your healthcare practitioner.
• Not recommended for use by pregnant or lactating women.
• May harm the liver.
• Always read the label. Use only as directed.

• This product is not recommended for use by pregnant or lactating women.
• There is some concern about using kava in depressed patients. Kava seems to have CNS depressant effects and theoretically might exacerbate depression in some patients.
• Concomitant use of this product (kava, lemon balm, motherwort) and alcohol, barbiturates, benzodiazepines or other CNS depressants can increase the risk of drowsiness, sedation and motor reflex depression.
• Theoretically, (kava, motherwort) might cause additive CNS depression when combined with anesthesia and other medications during and after surgical procedures. Discontinue kava at least 2 weeks before elective surgical procedures.
• Kava might adversely affect the liver, especially when taken for prolonged periods or in high doses. Even when used short-term in typical doses, kava might exacerbate hepatitis in patients with a history of recurrent hepatitis.
• Dopamine antagonism has been reported with kava; avoid with Parkinson's disease.
• Preliminary evidence suggests that kava inhibits cytochrome P450 1A2 (CYP1A2), CYP2C19, CYP2CP, CYP2D6, CYP2E1, CYP3A4 and therefore substrates of these liver enzymes.
• Lemon balm modestly reduces blood glucose levels in animal models. Theoretically, concomitant use of lemon balm and diabetes drugs might interfere with blood glucose control and results in blood glucose levels that are too low.
• In animals, lemon balm extract has been shown to decrease levels of circulating thyroid-stimulating hormone (TSH) and inhibited thyroid secretion. Theoretically, lemon balm may alter thyroid function, reduce thyroid hormone levels, and interfere with thyroid hormone-replacement therapy.
• Theoretically, holy basil seed oil might increase the risk of bleeding when combined with anticoagulant or antiplatelet drugs.

TGA Listed product with Aust L .

 Download TGA Public Summary for TGA published information including excipients, which are listed under 'Other Ingredients'.